Evidence map›Paper›PMID 33713028›Full record

ArticleTranslational stroke research2021

Ifenprodil Improves Long-Term Neurologic Deficits Through Antagonizing Glutamate-Induced Excitotoxicity After Experimental Subarachnoid Hemorrhage.

Jing-Yi Sun, Shi-Jun Zhao, Hong-Bin Wang, Ya-Jun Hou, Qiong-Jie Mi, Ming-Feng Yang, Hui Yuan, Qing-Bin Ni, Bao-Liang Sun, Zong-Yong Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  11. Article
  12. Review
  13. Common methods in mitochondrial research (Review).International journal of molecular medicine · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jing-Yi SunDepartment of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250021, Shandong, China.
Shi-Jun ZhaoDepartment of Neurology, Baotou Central Hospital, Baotou, 014040, Inner Mongolia, People's Republic of China.
Hong-Bin WangDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China.
Ya-Jun HouDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China.
Qiong-Jie MiDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China.
Ming-Feng YangDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China.
Hui YuanDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China.
Qing-Bin NiPostdoctoral Workstation, Taian City Central Hospital, Taian, 271000, Shandong, China.
Bao-Liang SunDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China. blsun88@163.com.
Zong-Yong ZhangDepartment of Neurology, Second Affiliated Hospital; Key Laboratory of Cerebral Microcirculation, Shandong First Medical University & Shandong Academy of Medical Sciences, Yingsheng East Road No.2, Taian, 271016, China. zyzhang@sdfmu.edu.cn.ORCID 0000-0002-0399-8027
Shandong First Medical University · CNBaotou Central Hospital · CNShandong Provincial Hospital · CNTaian City Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excessive glutamate leading to excitotoxicity worsens brain damage after SAH and contributes to long-term neurological deficits. The drug ifenprodil is a non-competitive antagonist of GluN1-GluN2B N-methyl-d-aspartate (NMDA) receptor, which mediates excitotoxic damage in vitro and in vivo. Here, we show that cerebrospinal fluid (CSF) glutamate level within 48 h was significantly elevated in aSAH patients who later developed poor outcome. In rat SAH model, ifenprodil can improve long-term sensorimotor and spatial learning deficits. Ifenprodil attenuates experimental SAH-induced neuronal death of basal cortex and hippocampal CA1 area, cellular and mitochondrial Ca

Indexed as

Glutamic AcidSubarachnoid HemorrhageAnimalsBlood-Brain BarrierHumansPiperidinesRatsReceptors, N-Methyl-D-AspartateGlutamic AcidifenprodilPiperidinesReceptors, N-Methyl-D-AspartateExcitotoxicityGlutamateIfenprodilSubarachnoid hemorrhage

Identifiers

PMID33713028
OpenAlexW3133506688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.